1. Home
  2. SUPN vs UTF Comparison

SUPN vs UTF Comparison

Compare SUPN & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.59

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$24.56

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
UTF
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SUPN
UTF
Price
$45.59
$24.56
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$63.25
N/A
AVG Volume (30 Days)
1.1M
171.7K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
7.19%
EPS Growth
N/A
N/A
EPS
N/A
2.84
Revenue
$681,539,000.00
$138,636,669.00
Revenue This Year
$8.29
N/A
Revenue Next Year
$22.72
N/A
P/E Ratio
N/A
$9.16
Revenue Growth
4.54
19.80
52 Week Low
$29.16
$22.05
52 Week High
$57.65
$26.53

Technical Indicators

Market Signals
Indicator
SUPN
UTF
Relative Strength Index (RSI) 43.24 61.35
Support Level $44.37 $23.43
Resistance Level $47.00 $24.08
Average True Range (ATR) 1.56 0.30
MACD -0.02 0.09
Stochastic Oscillator 55.51 97.17

Price Performance

Historical Comparison
SUPN
UTF

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

Share on Social Networks: